Related Experiment Videos
A comparison of leukocyte function and burn mortality
The Journal of Trauma
|January 1, 1980
Summary
Functional chemotactic index (FCI) in burn patients did not predict mortality, despite showing impaired leukocyte function. Other tests like nitroblue tetrazolium reduction also indicated host defense issues but lacked predictive value for survival.
Area of Science:
- Immunology
- Burn Injury Research
- Critical Care Medicine
Background:
- Leukocyte bactericidal competency is crucial in major thermal injury.
- Chemotaxis has been suggested to reflect both leukocyte dysfunction and patient mortality.
- Validating predictive markers for survival in burn patients is essential.
Purpose of the Study:
- To validate the reliability of the functional chemotactic index (FCI) as a predictor of mortality in burn patients.
- To compare FCI with nitroblue tetrazolium (NBT) reduction and O2 consumption in assessing host defense impairments.
Main Methods:
- Leukocytes were analyzed from 33 patients with >= 30% total body surface area burns.
- Functional chemotactic index (FCI) was measured.
- Nitroblue tetrazolium (NBT) reduction and O2 consumption assays were performed.
Main Results:
- FCI values were significantly decreased in burn patients compared to normal controls.
- No significant differences in FCI were observed between surviving and nonsurviving patients.
- NBT reduction and O2 consumption showed significant decreases, with differences between survivors and nonsurvivors.
Conclusions:
- While FCI, NBT reduction, and O2 consumption indicate impaired host defense in burn patients, they are not reliable predictors of patient survival.
- These laboratory tests should not be interpreted as indices of patient survival in major thermal injury.